The incident was triggered by a sudden after-hours announcement on Tuesday: CEO Andrew Witty, who had been at the helm for many years, suddenly announced his resignation, and the company also withdrew its previously released 2025 financial guidance, citing "a sudden change in the operating environment due to surging medical demand". This move triggered sharp market volatility, and the stock price plummeted the following day.
In a research report, Bank of America analyst Joanna Gajuk pointed out that this management earthquake directly disrupted UnitedHealth's strategic deployment. She downgraded the company from "buy" to "neutral" and sharply reduced her price target from $560 to $350, a decrease of 37.5%. The analyst predicts that United Health's earnings per share forecast for 2025 will shrink by 10%-20% compared to previous forecasts, and the reduction will be as high as 21%-29% compared to the initial long-term target.
The research report specifically emphasized that the decision to withdraw performance guidance reflects two deep-seated concerns: first, management lacks a basis for judging the sustainability and coverage of rising medical expenses; and second, it needs to allow sufficient time for the new CEO to reformulate strategic plans. It is worth noting that United Health revealed in the conference call that it is planning to formulate a new bidding strategy in the coming months, with the goal of restoring an operating profit margin of 3%-5% in the Medicare Advantage Plan (MA) segment, but this may come at the cost of stagnant or even lost membership growth.
Regarding the industry impact that the market is focusing on, Gazhuke believes that competitorsHamena(HUM.US)'s situation does not yet pose a systemic risk. She analyzed and pointed out that the current challenges facing Hamena stem more from the company's own governance problems, and the lightning departure of the CEO of United Health is more like a signal of internal management disorder than a sign of headwinds in the entire health management industry.
This sudden management earthquake not only exposed the vulnerability of health insurance giants under the pressure of medical inflation, but also triggered the market to re-examine the valuation system of the medical sector. As the 2025 medical insurance bidding season approaches, the industry may usher in a new round of strategic adjustment cycle.
